Indocyanine green fluorescence perfusion testing in robot-assisted hepatic arterial infusion pump placement
- PMID: 39017958
- PMCID: PMC11893147
- DOI: 10.1007/s00464-024-11010-7
Indocyanine green fluorescence perfusion testing in robot-assisted hepatic arterial infusion pump placement
Abstract
Background: Hepatic arterial infusion pump (HAIP) treatment is a technique used to treat liver localized malignancy with intra-arterial chemotherapy. Methylene blue is generally administered to verify hepatic perfusion and exclude inadvertent extrahepatic perfusion. The use of indocyanine green dye (ICG) combined with near-infrared (NIR) fluorescence imaging during robot-assisted HAIP placement may be an attractive alternative by providing high contrast without blue discoloration of the operative field.
Methods: Data was collected retrospectively from 2 centers in the Netherlands. Intraoperative perfusion of the liver segments and extrahepatic perfusion were assessed using ICG/NIR as well as methylene blue on video imaging and correlated to postoperative 99 m-Tc perfusion scintigraphy.
Results: 13 patients underwent robot-assisted surgery for HAIP placement; median length of stay was 4 days, complications occurred in 4 patients. Hepatic perfusion showed identical patterns when ICG was compared with methylene blue. In 1 patient, additional extrahepatic perfusion was found using ICG, leading to further vessel ligation. Intraoperative ICG perfusion was concordant with 99 m-Tc perfusion scintigraphy.
Discussion: Liver and extrahepatic perfusion determined by ICG fluorescence imaging is concordant with blue dye perfusion and 99 m-Tc perfusion scintigraphy. Therefore, ICG fluorescence imaging is deemed a safe and reliable technique for perfusion testing during robot-assisted HAIP placement.
Keywords: Chemotherapy; Fluorescence; Robot-assisted surgery.
© 2024. The Author(s).
Conflict of interest statement
Roderick van Dorst, Britte ten Haaft, Stijn Franssen, Inne Borel Rinkes, Bas Groot Koerkamp, Rutger-Jan Swijnenburg and Jeroen Hagendoorn have no conflicts of interest or financial ties to disclose.
Figures
References
-
- Leal JN, Kingham TP (2015) Hepatic artery infusion chemotherapy for liver malignancy. Surg Oncol Clin N Am 24(1):121–148. 10.1016/j.soc.2014.09.005 - PubMed
-
- Link KH, Kornmann M, Leder G, Pillasch AF, Sunelaitis E, Schatz M et al (1999) Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU+folinic acid and mitomycin C. Gan To Kagaku Ryoho 26(3):269–281 - PubMed
-
- Allen PJ, Nissan A, Picon AI, Kemeny N, Dudrick P, Ben-Porat L et al (2005) Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases. J Am Coll Surg 201(1):57–65. 10.1016/j.jamcollsurg.2005.03.019 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous